Biotechnology in Healthcare: Biopharmaceuticals and Biosimilars

The rise of recombinant DNA technology and advanced biotechnology is transforming how we treat complex diseases like cancer, autoimmune disorders, and genetic conditions. To work in modern healthcare, research, or pharmaceuticals, understanding the shift from traditional chemical drugs to complex biological therapies is essential. This text-based course provides a comprehensive foundation in health biotechnology, focusing on biopharmaceuticals and biosimilars. You will transition from knowing basic drug concepts to understanding how complex living systems are engineered to manufacture life-saving therapies, preparing you for the future of the pharmaceutical industry. What you'll learn: - Understand the foundational science of recombinant DNA technology and cell line development. - Differentiate between traditional small-molecule chemical drugs and complex biopharmaceuticals. - Analyze the scientific and regulatory requirements for biosimilar approval and substitution. - Explore the clinical applications of monoclonal antibodies, vaccines, and modern gene therapies. - Evaluate market trends, production challenges, and the role of biotechnology in personalized medicine. You will begin with essential terminology, historical context, and biological foundations before exploring the manufacturing, regulation, and clinical use of biosimilars. The material is structured through clear written explanations, real-world case studies, and conceptual review exercises. Designed for healthcare professionals, life sciences students, and industry newcomers, this course requires no prior biotechnology experience. Start reading today to build a strong foundation in the future of medicine.